Early Thrombolysis Guided by AI-Assisted App in Patients With STEMI
Recruiting
N/A
Interventional Study
STEMI - ST Elevation Myocardial Infarction
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 3,356 (estimated)
- Sponsor
- Shenyang Northern Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of the study is to elucidate whether guiding by a novel artificial intelligence assisted mobile application can improve the clinical outcomes of patients in whom "guide wire passing through the lesion" could not be achieved within 120 min after diagnosis of STEMI, compared to conventional treatment strategies. With concerns of the inadequate use of thrombolysis in patients with STEMI in Ch…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* (the following inclusion conditions shall be met at the same time):
1. age: ≥ 18 years and ≤ 80 years;
2. Chest pain lasted for more than 30 min, and the onset time of chest pain was ≤ 12 hours;
3. ECG: ST segment elevation after J-point in 2 or more adjacent leads: lim…
Contacts